What is ResMed's R&D?

ResMed (RMD) reported R&D of $94.27M in Q1 2026.

How has ResMed's R&D changed year-over-year?

ResMed's R&D increased by 12.3% year-over-year, from $83.94M to $94.27M.

What is the long-term trend for ResMed's R&D?

Over 3 years (2022 to 2025), ResMed's R&D has grown at a 9.3% compound annual growth rate (CAGR), from $253.58M to $331.28M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

ResMed RMD R&D

Discontinued — last reported Q3 '26

R&D at other companies

Eli LillyLLY

$3.51B+28.4%

Inspire Medical SystemsINSP

$25.83M-7.1%

Viemed Healthcare, Inc.VMD

$579K-27.4%

LivaNovaLIVN

$58.7M+55.0%

MedtronicMDT

$671M-1.9%

InsmedINSM

$209.49M+37.3%

Segments

By segment

See full

Sleep And Breathing Health$56.41M+19.4%

Residential Care Software$26.23M+5.3%

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$29.05B-25.2%

Enterprise value$28.5B-26.0%

P/E19.1×-8.6×

P/S5.3×-2.3×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's R&D?: ResMed (RMD) reported R&D of $94.27M in Q1 2026.
How has ResMed's R&D changed year-over-year?: ResMed's R&D increased by 12.3% year-over-year, from $83.94M to $94.27M.
What is the long-term trend for ResMed's R&D?: Over 3 years (2022 to 2025), ResMed's R&D has grown at a 9.3% compound annual growth rate (CAGR), from $253.58M to $331.28M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.